Skip to main content

Biktarvy Prices, Coupons, Copay Cards & Patient Assistance

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.

The cost for Biktarvy (50 mg-200 mg-25 mg) oral tablet is around $4,511 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Biktarvy is available as a brand name drug only, a generic version is not yet available. View generic Biktarvy availability for more details.

Biktarvy prices

Oral Tablet

30 mg-120 mg-15 mg

Biktarvy oral tablet

 from $4,510.77

for 30 tablets
Quantity Per unit Price
30 $150.36 $4,510.77

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

50 mg-200 mg-25 mg

Biktarvy oral tablet

 from $4,510.77

for 30 tablets
Quantity Per unit Price
30 $150.36 $4,510.77

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Biktarvy Coupons, Copay Cards and Rebates

Biktarvy offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Biktarvy Advancing Access Co-pay Program

Eligible commercially insured patients may save up to a maximum of $7200 per year with no monthly limits.

Applies to:
Biktarvy
Number of uses:
per prescription per year

Form more information phone: 800-226-2056 or Visit website

Biktarvy Advancing Access Co-pay Program Direct Member Reimbursement

Eligible commercially insured patients may be eligible for reimbursement if they were enrolled in the Co-pay Program but paid in full out of pocket for their medication.

Applies to:
Biktarvy
Number of uses:
One rebate per prescription fill

Form more information phone: 800-226-2056 or Visit website

Patient Assistance & Copay Programs for Biktarvy

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Advancing Access Program

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or Puerto Rico
  5. This program is for outpatient use only. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. *IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
Applicable drugs:
  • Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 800-226-2056 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: Good Days Program

Eligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
  • Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet

More information please phone: 877-968-7233 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.